Combinations of biological response modifiers: rationale and clinical responses.
Natoli
C
C
Cattedra di Oncologia Medica Università G. D'Annunzio, Chieti.
Fiorentino
B
B
Di Stefano
P
P
Amatetti
C
C
Tinari
N
N
Iacobelli
S
S
D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D007958:Leukocyte Count; D008214:Lymphocytes / Q000187:drug effects / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy*; D011994:Recombinant Proteins
D007155:Immunologic Factors; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins